#atrial_fibrillation_ablation

Why Your Address Can Outrank Your Heart’s Stroke Score

Medically Reviewed by Dr. Şekip Altunkan on Oct 29, 2026.
Medical illustration from Vitals Daily

Executive Summary

For years, we have stratified stroke risk in atrial fibrillation as though biology told the entire story. Drawing on UK Biobank data, this new analysis demonstrates that severe socioeconomic deprivation nearly doubles stroke incidence, potentially propelling a seemingly “low-risk” patient ahead of one categorized as “intermediate-risk.” While recalibrating our clinical perspective is long overdue, altering prescribing practices must await prospective clinical trial outcomes.

Two Patients, One Score, Two Very Different Futures

Consider two 62-year-old men walking out of the same cardiology clinic, each with a fresh diagnosis of atrial fibrillation. Neither has any clinical risk factors beyond well-controlled hypertension; consequently, both carry a CHA2DS2-VA score of 1. One patient drives home to a mortgage-free residence in a quiet suburb. The other returns to a damp rental apartment beside a bustling highway, three months behind on rent after losing his warehouse job. On paper, their stroke risks are identical, and clinical practice guidelines recommend the exact same therapeutic pathway for both. Yet any seasoned internist instinctively knows that paper rarely captures the full clinical reality. A compelling new analysis reveals that this…

Medically reviewed by

Dr. Şekip Altunkan

Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."

Share this article